Dt-diaphorase activity and mitomycin c sensitivity in non-transformed cell strains derived from members of a cancer-prone family

Carcinogenesis

Volumn 12, Issue 7, 1991, Pages 1175-1180

  Marshall, Raymond S ^a   Paterson, Malcolm C ^a,b   Rauth, A M ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; MITOMYCIN C; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE);

ARTICLE; CANCER SUSCEPTIBILITY; CELL LINE; CONTROLLED STUDY; DRUG METABOLISM; DRUG RESISTANCE; ENZYME ACTIVITY; ENZYME INACTIVATION; FAMILY; GENETIC DISORDER; HUMAN; HUMAN CELL; NUCLEIC ACID ANALYSIS; PRIORITY JOURNAL; RNA TRANSLATION; SKIN FIBROBLAST; TOPICAL DRUG ADMINISTRATION; VOLUNTEER;

ADOLESCENT; ADULT; AGED; DNA; DRUG RESISTANCE; FEMALE; FIBROBLASTS; HUMAN; MALE; MIDDLE AGE; MITOMYCIN; MITOMYCINS; NAD(P)H DEHYDROGENASE (QUINONE); NEOPLASMS; QUINONE REDUCTASES; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0025799465     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/12.7.1175     Document Type: Article

References (40)

1. Marshall, R.S., Paterson, M.C. and Rauth, A.M. (1989) Deficient activation by a human cell strain leads to mitomycin resistance under aerobic but not hypoxic conditions. Br. J. Cancer, 59, 341-346.
2. Kennedy K. A., Rockwell, S. and Sartorelli, A.C. (1980) Preferential activation of mitomycin C to cytotoxic metabolites by hypoxic tumor cells. Cancer Res., 40, 2356-2360.
3. Sartorelli, A.C. (1988) Therapeutic attack of hypoxic cells of solid tumors: presidential address. Cancer Res., 48, 775-778.
4. Pan, S.S., Andrews, P.A. and Glover, C.J. (1984) Reductive activation of mitomycin C and mitomycin C metabolites catalyzed by NADPH-cytochrome P450 reductase and xanthine oxidase. J. Biol. Oiem., 259, 959-966.
5. Keyes, S.R., Fracasso, P.M., Heimbrook, D.C., Rockwell, S., Sligar, S.G. and Sartorelli, A.C. (1984) Role of NADPH: cytochrome c reductase and DT-diaphorase in the biotransformation of mitomycin C. Cancer Res., 44, 5638-5643.
6. Emster, L. (1987) DT-diaphorase: a historical review. Chem. Scrip., 27A, 1-13.
7. Marshal], R.S., Paterson, M.C. and Rauth, A.M. (1991) Studies on the mechanism of resistance to mitomycin C and porfiromycin in a human cell strain derived from a cancer-prone individual. Biochem. Pharmacol., 41, 1351-1360.
8. Dulhanty, A.M. and Whitmore, G.F. (1991) Chinese hamster ovary cell lines resistant to mitomycin C under aerobic but not hypoxic conditions are deficient in DT-diaphorase. Cancer Res., 51, 1860-1865.
9. Begleiter, A., Robotham, E., Lacey, G. and Leith, M.K. (1989) Increased sensitivity of quinone resistant cells to mitomycin C. Cancer Lett., 45, 173-176.
10. Fraumeni, J., Vogel, C. and Easton, J. (1968) Sarcomas and multiple polyposis in a kindred: A genetic variety of hereditary polyposis? Arch. Intern. Med., 121, 57-61.
11. Wright, A.S. (1980) The role of metabolism in chemical mutagenesis and chemical carcinogenesis. Mutat.Res., 75, 215-241.
12. Talalay, P., DeLong, M.J. and Prochaska, H J. (1987) Molecular mechanisms in protection against carcinogenesis. In Lee Moffitt, H. (ed.), Cancer Biology and Therapeutics. Plenum Press, New York, pp. 197-216.
13. Lind, C., Hochstein, P. and Emster, L. (1982) DT-diaphorase as a quinone reductase: a cellular control device against semiquinone radical formation. Arch. Biochem. Biophys., 216, 178-185.
14. Paterson, M.C., Middlestadt, M.V., Weinfeld, M., Mirzayans, R. and Gentner, N.E. (1986) Human cancer-prone disorders, abnormal carcinogen response and defective DNA metabolism. In Bums, F.J., Upton, A.C. and Silini, G. (eds), Radiation Carcinogenesis and DNA Alterations. Plenum Press, New York, pp. 471-498.
15. Emster, L. (1967) DT-diaphorase. Methods Enzymol., 10, 309-317.
16. Benson, A.M., Henkeler, M.J. and Talalay, P. (1980) Increase of NAD(P)H:quinone reductase by dietary antioxidants: possible role in protection against carcinogenesis and toxicity. Proc. Natl. Acad. Sd. USA, 77, 5216-5220.
17. Williams, J.B., Wang, R., Lu, A.Y.H. and Pickett, C.B. (1984) Rat liver DT-diaphorase: Regulation of functional mRNA levels by 3-methylchol- anthrene rranr-stilbene oxide and phenobarbital. Arch. Biochem. Biophys., 232, 408-412.
18. Southern, E.M. (1975) Detection of specific sequences among DNA fragments separated by gel electrophoresis. J. Mol. Biol., 98, 513-517.
19. Dulhanty, A.M., Rubin, J.S. and Whitmore, G.F. (1988) Complementation of the DNA-repair defect in a CHO mutant by human DNA that lacks highly abundant repetitive sequences Mutat. Res., 194, 207-217.
20. Rigby, P.W.J., Dieckmann, M., Rhodes, C. and Berg, P. (1987) Labeling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase I. J. Mol. Biol., 113, 237-251.
21. Williams, L.B., Lu, A.Y.H., Cameron, R.G. and Pickett, C.B. (1986) Rat liver NAD(P)H:quinone reductase. Construction of a quinone reductase cDNA clone and regulation of quinone reductase mRNA by 3-methylcholanthrene and in persistent hepatocyte nodules induced by chemical carcinogenesis. J. Mol. Biol., 261, 5524-5528.
22. Chirgwin, J.M., Przybyla, A.E. and MacDonald, R.J. (1979) Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry, 18, 5294-5299.
23. Foumey, R., Miyakoshi J., Day, R.S. III and Paterson, M.C. (1988) Northern • blotting: efficient RNA staining and transfer. Focus, 10, 5-7.
24. Feinberg, A.P. and Vogelstein, B. (1983) A technique for labelling DNA restriction endonuclease fragments to high specific activity. Anal. Biochem., 132, 6-13.
25. Gunning, P., Ponte, G., Okayama, H., Engel, J., Blau, H. and Kedes, L. (1983) Isolation and characterization of full-length cDNA clones for human α-, β-and y-actin mRNAs: skeletal but not cytoplasmic actins have an amino-terminal cysteine that is subsequently removed. Mol. Cell Biol., 3, 787-795.
26. Jaiswal, A.K., McBride, O.W., Adesnik, M. and Nebert, D.W. (1988) Human dioxin-inducible cytosolic NAD(P)H:menadione oxidoreductase cDNA sequence and localization of gene to chromosome 16. J. Biol. Chem., 263, 13572-13578.
27. Takahashi, T., D’Amico, D., Chiba, J., Buchhagen, D.L. and Minna, J.D. (1990) Identification of intronic point mutations as an alternative mechanism for p53 inactivation in lung cancer. J. Clin. Invest., 86, 363-369.
28. Pritsos, C.A., Pardini, L.L., Elliott, A.J. and Pardini, R.S. (1987) Relationship between the antioxidant enzyme DT-diaphorase and tumor response to mitomycin C treatment. In Simic, M.G. ami Taylor, K.A. (eds), Oxygen Radicals in Biology and Medicine. Plenum Press, New York, pp. 713-716.
29. Schlager, J.J. and Powis, G. (1988) Mitomycin C is not metabolized by but is an inhibitor of human kidney. NAD(P)H:(quinone-acceptor) oxidoreductase. Cancer Chemother. Pharmacol., 22, 126-130.
30. Siegel, D., Gibson, N.W., Preusch, P.C. and Ross, D. (1990) Metabolism of mitomycin C by DT-diaphorase: role in mitomycin C-induced DNA damage and cytotoxicity in human colon carcinoma cells. Cancer Res., 50, 7483-7489.
31. Segura-Aguilar, J.E. and Lind, C. (1987) Isolation and characterization of DT-diaphorase isozymes from rat liver. Chem. Scrip., 27A, 37-41.
32. DeLong, M.J., Santamaria, A.B. and Talalay, P. (1987) Role of cytochrome P!-450 in the induction of NAD(P)H:quinone reductase in a murine hepatoma line and its mutant. Carcinogenesis, 8, 1549-1559.
33. Pickett, C.B., Williamsr, J.B., Lu, A.Y.H. and Cameron, R.G. (1984) Regulation of glutathione transferase and DT-diaphorase mRNAs in persistent hepatocyte nodules during chemical hepatocarcinogenesis. Proc. Natl. Acad. Sci. USA, 81, 5091-5095.
34. Hoban, P., Walton, M., Robson, C., Godden, J., Stratford, I., Workman, P., Harris, A. and Hickson, I. (1990) Decreased NADPH:cytochrome reductase activity and impaired drug activation in a mammalian cell line resistant to mitomycin C under aerobic but not hypoxic conditions. Cancer Res., 50, 4692-4697.
35. Thor, H., Smith, M.T., Hartzell, P., BeDomo, G., Jewele, S.A. and Orrenius, S. (1982) The metabolism of menadione (2-methyl 1, 4-napthoquinone) by isolated hepalocytes. A study of the implications of oxidative stress m intact cells. J. Biol. Chem., 257, 12419-12425.
36. DeLong, M.J., Prochaska, H.J. and Talalay, P. (1986) Induction of NAD(P)H:quinone reductase in murine hepatoma cells by phenolic antioxidants, azo dyes and other chemoprotectors: a model system for the study of anticarcinogens. Proc. Natl. Acad. Sd. USA, 83, 787-791.
37. Swanson, M.S., Haugen, D.A., Reilly, C.A. and Stamoudis, V.C. (1986) Protection by uridine diphosphoglucuronic acid and DT-diaphorase against the cytotoxicity of polycyclic aromatic hydrocarbons isolated from a complex coal gasification condensate. Toxicol. AppL Pharmacol., 84, 336-345.
38. Schor, N. and Comelisse, C.J. (1983) Biochemical and quantitative histochemical study of reduced pyridine nucleotide dehydrogenation by human colonic carcinomas. Cancer Res., 43, 4850-4855.
39. Mekhail-Ishak, K., Hudson, N., Tsao, M.S. and Batist, G. (1989) Implications for therapy of drug-metabolizing enzymes in human colon cancer. Cancer Res., 49, 4866-4869.
40. DeFlora, S., Bennicelli, C., Camoirano, A., Serra, D. and Hochstein, P. (1988) Influence of DT-diaphorase on the mutagenicity of organic and inorganic compounds. Carcinogenesis, 9, 611-617.